Treatment-Resistant Melasma Response to Oral Tranexamic Acid

Journal Title: Journal of Dermatology Research - Year 2024, Vol 5, Issue 3

Abstract

Melasma, a common acquired hyperpigmentation disorder primarily affecting facial skin, poses significant therapeutic challenges due to the limited efficacy and potential side effects of available treatments. Tranexamic Acid (TXA), traditionally used for its hemostatic properties by inhibiting plasminogen activation, has emerged as a promising addition to protocols for treatment-resistant melasma. This study aims to evaluate the efficacy and safety of TXA in combination with Hydroquinone (HQ) and Kojic Acid (KA) in patients with treatment-resistant melasma. We present here a case series of fourteen patients with recurrent melasma refractory to common treatments who achieved successful outcomes with the addition of TXA to their treatment regimen. These patients received 650 mg of TXA in combination with 16% HQ and 6% KA. All patients exhibited a symmetrical reduction in their hyperpigmented patches following treatment and no significant adverse effects were reported. These cases contribute valuable input to the growing body of evidence on the use of TXA for melasma and the combination of treatments and dosing, suggesting its potential as a therapeutic option for this condition. Further research is warranted to explore the mechanisms by which TXA exerts its beneficial effects in melasma and to determine the optimal treatment protocols for achieving effective clinical outcomes.

Authors and Affiliations

Laura Duzett, Bradley Boman, Alison Tam,

Keywords

Related Articles

Vulvar Lesion Mimicking Vitiligo Revealing a Squamous Cell Carcinoma

Melanocytes respond to trauma or cutaneous inflammation by producing varying amounts of melanin, which manifests as either hyperpigmentation or hypopigmentation. Post inflammatory Hypopigmentation (PIH) is an acquired pa...

A Survey on Neonatal and Infant Skincare: Indian Dermatologists, Pediatricians and Cosmetologists' Perspective on Product Prescription Pattern and Parents’ Awareness

Objective: Newborn skin is incredibly delicate and vulnerable to issues like dermatitis and infections, which are prevalent in infants in India. To ensure optimal care and results, parents and caregivers must know about...

Severe Ulcers in Oral Mucosa Due to Cytomegalovirus in an Immunosuppressed Pediatric Patient

Cutaneous expressions in cytomegalovirus infection are rare and their clinical manifestations in immunosuppressed patients are diverse; for example, ulcerative forms. Therefore, cytomegalovirus infection should be cons...

Long-Term Efficacy of Dupilumab for the Treatment of Prurigo Nodularis: A Case Series

Prurigo nodularis is a chronic, pruritic dermatologic condition that results in nodule formation on the skin that is often treatment refractory and can impair quality of life. The underlying biological mechanism of pruri...

Longer Intervals Between Sessions With Q-Switched and Picosecond Lasers Result in Enhanced Tattoo Ink Clearance: Case Study Series of 12 Patients

Twelve case studies are presented showing results following laser tattoo removal with Nd:YAG, ruby and alexandrite lasers utilising both nanosecond and picosecond pulsewidth modes in a range of applied radiant exposures...

Download PDF file
  • EP ID EP747051
  • DOI https://doi.org/10.46889/JDR.2024.5304
  • Views 1
  • Downloads 0

How To Cite

Laura Duzett, Bradley Boman, Alison Tam, (2024). Treatment-Resistant Melasma Response to Oral Tranexamic Acid. Journal of Dermatology Research, 5(3), -. https://europub.co.uk/articles/-A-747051